Risk factors, clinical features, and impact on survival of lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective study

Medicine 2026 Open access

Read full text
Authors: Hasibe Çiğdem Erten, Sevda Şener Cömert, Talha Doğruyol, Ali Fidan, Gonca Gul Gecmen, Cihan Akgül Özmen, Sümeyye Kodalak Cengiz, Saibe Fulya Elmastaş Akkuş, Recep Demirhan
DOI: 10.1097/md.0000000000047714
Cited by: 1
References: 27

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease, and lung cancer is a significant comorbidity with high prevalence and adverse impact on survival. Early detection of IPF and targeted interventions require understanding the associated risk factors and clinical presentation of lung cancer in IPF. This single-center, retrospective cohort study aimed to identify risk factors for lung cancer in IPF patients, investigate its clinical features, and determine its impact on survival. Of the 1481 patients with interstitial lung disease, 436 met the criteria for IPF per American Thoracic Society/European Respiratory Society guidelines. Patients followed up for

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Systemic Sclerosis and Related Diseases Sarcoidosis and Beryllium Toxicity Research

Publication details

Journal / source
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
105
Issue
7
Pages
e47714–e47714
Publication date
13 February 2026
Language
EN